147 related articles for article (PubMed ID: 28681697)
41. Abnormal expression of Tim-3 antigen on peripheral blood T cells is associated with progressive disease in osteosarcoma patients.
Liu H; Zhi L; Duan N; Su P
FEBS Open Bio; 2016 Aug; 6(8):807-15. PubMed ID: 27516959
[TBL] [Abstract][Full Text] [Related]
42. Differential expression of T cell immunoglobulin- and mucin-domain-containing molecule-3 (TIM-3) according to activity of Behçet's disease.
Lee JS; Park MJ; Park S; Lee ES
J Dermatol Sci; 2012 Mar; 65(3):220-2. PubMed ID: 22336995
[No Abstract] [Full Text] [Related]
43. Modulation of TIM-3 expression on NK and T cell subsets in HIV immunological non-responders.
de Kivit S; Lempsink LJ; Plants J; Martinson J; Keshavarzian A; Landay AL
Clin Immunol; 2015 Jan; 156(1):28-35. PubMed ID: 25450337
[TBL] [Abstract][Full Text] [Related]
44. Regulation of T cell responses by the receptor molecule Tim-3.
Gorman JV; Colgan JD
Immunol Res; 2014 Aug; 59(1-3):56-65. PubMed ID: 24825777
[TBL] [Abstract][Full Text] [Related]
45. PD-1 and Tim-3 pathways are associated with regulatory CD8+ T-cell function in decidua and maintenance of normal pregnancy.
Wang SC; Li YH; Piao HL; Hong XW; Zhang D; Xu YY; Tao Y; Wang Y; Yuan MM; Li DJ; Du MR
Cell Death Dis; 2015 May; 6(5):e1738. PubMed ID: 25950468
[TBL] [Abstract][Full Text] [Related]
46. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.
Theyer G; Kramer G; Assmann I; Sherwood E; Preinfalk W; Marberger M; Zechner O; Steiner GE
Lab Invest; 1992 Jan; 66(1):96-107. PubMed ID: 1370561
[TBL] [Abstract][Full Text] [Related]
47. Decreased Tim-3 and its correlation with Th1 cells in patients with immune thrombocytopenia.
Shan NN; Hu Y; Hou M; Gao J; Wang X; Liu X; Li Y
Thromb Res; 2014 Jan; 133(1):52-6. PubMed ID: 24231118
[TBL] [Abstract][Full Text] [Related]
48. Characterization of age-associated exhausted CD8⁺ T cells defined by increased expression of Tim-3 and PD-1.
Lee KA; Shin KS; Kim GY; Song YC; Bae EA; Kim IK; Koh CH; Kang CY
Aging Cell; 2016 Apr; 15(2):291-300. PubMed ID: 26750587
[TBL] [Abstract][Full Text] [Related]
49. Upregulation of T-cell Immunoglobulin and Mucin-Domain Containing-3 (Tim-3) in Monocytes/Macrophages Associates with Gastric Cancer Progression.
Wang Z; Yin N; Zhang Z; Zhang Y; Zhang G; Chen W
Immunol Invest; 2017 Feb; 46(2):134-148. PubMed ID: 27911104
[TBL] [Abstract][Full Text] [Related]
50. PD-1 and its ligand PD-L1 are progressively up-regulated on CD4 and CD8 T-cells in HIV-2 infection irrespective of the presence of viremia.
Tendeiro R; Foxall RB; Baptista AP; Pinto F; Soares RS; Cavaleiro R; Valadas E; Gomes P; Victorino RM; Sousa AE
AIDS; 2012 Jun; 26(9):1065-71. PubMed ID: 22441249
[TBL] [Abstract][Full Text] [Related]
51. Expression of the Th1-specific cell-surface protein Tim-3 increases in a murine model of atopic asthma.
Hu WK; Lu XX; Yang S; Xu GP; Lan F; Chen SX; Ni W; Xiong WN; Xiong SD
J Asthma; 2009 Nov; 46(9):872-7. PubMed ID: 19905911
[TBL] [Abstract][Full Text] [Related]
52. Increased expression of T cell immunoglobulin- and mucin domain-containing molecule-3 on natural killer cells in atherogenesis.
Hou N; Zhao D; Liu Y; Gao L; Liang X; Liu X; Gai X; Zhang X; Zhu F; Ni M; Zhang Y; Sun W; Ma C
Atherosclerosis; 2012 May; 222(1):67-73. PubMed ID: 22387059
[TBL] [Abstract][Full Text] [Related]
53. CD4+ and CD8+ T-lymphocyte scores cannot reliably predict progression in patients with benign prostatic hyperplasia.
Lamb AD; Qadan M; Roberts S; Timlin H; Vowler SL; Campbell FM; Grigor K; Bartlett JM; McNeill SA
BJU Int; 2011 Jul; 108(2 Pt 2):E43-50. PubMed ID: 21457430
[TBL] [Abstract][Full Text] [Related]
54. Blocking Tim-3 enhances the anti-tumor immunity of STING agonist ADU-S100 by unleashing CD4
Luo J; Pang S; Hui Z; Zhao H; Xu S; Yu W; Yang L; Sun Q; Hao X; Wei F; Wang J; Ren X
Theranostics; 2023; 13(14):4836-4857. PubMed ID: 37771774
[No Abstract] [Full Text] [Related]
55. Occupational Low-Dose Radiation Affects the Expression of Immune Checkpoint of Medical Radiologists.
Wang C; Hao C; Dai K; Li Y; Jiao J; Niu Z; Xu X; Deng X; He J; Yao W
Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742351
[TBL] [Abstract][Full Text] [Related]
56. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B.
Ju Y; Hou N; Meng J; Wang X; Zhang X; Zhao D; Liu Y; Zhu F; Zhang L; Sun W; Liang X; Gao L; Ma C
J Hepatol; 2010 Mar; 52(3):322-9. PubMed ID: 20133006
[TBL] [Abstract][Full Text] [Related]
57. The Clinical Significance of Abnormal Tim-3 Expression on NK Cells from Patients with Gastric Cancer.
Wang Z; Zhu J; Gu H; Yuan Y; Zhang B; Zhu D; Zhou J; Zhu Y; Chen W
Immunol Invest; 2015; 44(6):578-89. PubMed ID: 26214042
[TBL] [Abstract][Full Text] [Related]
58. PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer.
Severson JJ; Serracino HS; Mateescu V; Raeburn CD; McIntyre RC; Sams SB; Haugen BR; French JD
Cancer Immunol Res; 2015 Jun; 3(6):620-30. PubMed ID: 25701326
[TBL] [Abstract][Full Text] [Related]
59. T-cell immunoglobulin domain and mucin domain 3 polymorphism affects cytokine expression in different cells and is associated with increased susceptibility to knee osteoarthritis.
Chen J; Sun G; Chen F; Fang Y; Gates MH; Yang S
Gene; 2015 Jul; 566(1):32-6. PubMed ID: 25876049
[TBL] [Abstract][Full Text] [Related]
60. Co-expression of TIM-3 and CEACAM1 promotes T cell exhaustion in colorectal cancer patients.
Zhang Y; Cai P; Li L; Shi L; Chang P; Liang T; Yang Q; Liu Y; Wang L; Hu L
Int Immunopharmacol; 2017 Feb; 43():210-218. PubMed ID: 28038383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
